Cluster composition

Functions

Category	Name	IntersectionWithQuery	PValue	GenesInTerm	GenesInQuery	GenesInTermInQuery	ID
GeneOntologyMolecularFunction	long-chain-3-hydroxyacyl-CoA dehydrogenase activity	EHHADH HADHA	5.90e-06	2	49	2	GO:0016509
GeneOntologyMolecularFunction	3-hydroxyacyl-CoA dehydrogenase activity	EHHADH HADHA	8.79e-05	6	49	2	GO:0003857
GeneOntologyMolecularFunction	3-hydroxyacyl-CoA dehydratase activity	EHHADH HADHA	1.64e-04	8	49	2	GO:0018812
GeneOntologyMolecularFunction	uniporter activity	SLC16A12 SLC2A4	2.62e-04	10	49	2	GO:0015292
GeneOntologyMolecularFunction	enoyl-CoA hydratase activity	EHHADH HADHA	3.83e-04	12	49	2	GO:0004300
GeneOntologyMolecularFunction	transmembrane receptor protein tyrosine kinase activity	EFNB3 CRIM1 NRP1	5.45e-04	65	49	3	GO:0004714
GeneOntologyMolecularFunction	NAD binding	EHHADH HADHA NDUFV1	7.65e-04	73	49	3	GO:0051287
GeneOntologyMolecularFunction	NAD+ binding	EHHADH HADHA	1.09e-03	20	49	2	GO:0070403
GeneOntologyMolecularFunction	transmembrane receptor protein kinase activity	EFNB3 CRIM1 NRP1	1.19e-03	85	49	3	GO:0019199
GeneOntologyMolecularFunction	monocarboxylic acid transmembrane transporter activity	SLCO2B1 SLC2A1 SLC16A12	1.40e-03	90	49	3	GO:0008028
GeneOntologyMolecularFunction	adrenergic receptor binding	SH3GL1 GNAS	1.57e-03	24	49	2	GO:0031690
GeneOntologyMolecularFunction	flavin adenine dinucleotide binding	MAOB COQ6 ACOX3	1.59e-03	94	49	3	GO:0050660
GeneOntologyMolecularFunction	D-glucose transmembrane transporter activity	SLC2A1 SLC2A4	1.71e-03	25	49	2	GO:0055056
GeneOntologyMolecularFunction	hexose transmembrane transporter activity	SLC2A1 SLC2A4	1.71e-03	25	49	2	GO:0015149
GeneOntologyMolecularFunction	protein-cysteine S-palmitoyltransferase activity	ZDHHC18 ZDHHC24	1.85e-03	26	49	2	GO:0019706
GeneOntologyMolecularFunction	protein-cysteine S-acyltransferase activity	ZDHHC18 ZDHHC24	1.85e-03	26	49	2	GO:0019707
GeneOntologyMolecularFunction	monosaccharide transmembrane transporter activity	SLC2A1 SLC2A4	1.99e-03	27	49	2	GO:0015145
GeneOntologyMolecularFunction	sugar transmembrane transporter activity	SLC2A1 SLC2A4	2.30e-03	29	49	2	GO:0051119
GeneOntologyMolecularFunction	S-acyltransferase activity	ZDHHC18 ZDHHC24	2.46e-03	30	49	2	GO:0016417
GeneOntologyMolecularFunction	palmitoyltransferase activity	ZDHHC18 ZDHHC24	3.72e-03	37	49	2	GO:0016409
GeneOntologyMolecularFunction	carbohydrate transmembrane transporter activity	SLC2A1 SLC2A4	4.77e-03	42	49	2	GO:0015144
GeneOntologyMolecularFunction	FAD binding	COQ6 ACOX3	5.23e-03	44	49	2	GO:0071949
GeneOntologyMolecularFunction	protein tyrosine kinase activity	EFNB3 CRIM1 NRP1	5.41e-03	145	49	3	GO:0004713
GeneOntologyMolecularFunction	secondary active transmembrane transporter activity	SLCO2B1 TMEM165 SLC16A12 SLC2A4	5.94e-03	296	49	4	GO:0015291
GeneOntologyMolecularFunction	active transmembrane transporter activity	SLCO2B1 TMEM165 SLC16A12 NDUFV1 SLC2A4	6.12e-03	477	49	5	GO:0022804
GeneOntologyBiologicalProcess	fatty acid beta-oxidation using acyl-CoA oxidase	EHHADH AMACR ACOX3	2.90e-06	12	50	3	GO:0033540
GeneOntologyBiologicalProcess	fatty acid beta-oxidation	EHHADH AMACR HADHA ACOX3	4.22e-05	80	50	4	GO:0006635
GeneOntologyBiologicalProcess	transport across blood-brain barrier	SLCO2B1 SLC2A1 SLC16A12 SLC2A4	5.86e-05	87	50	4	GO:0150104
GeneOntologyBiologicalProcess	vascular transport	SLCO2B1 SLC2A1 SLC16A12 SLC2A4	6.13e-05	88	50	4	GO:0010232
GeneOntologyBiologicalProcess	lipid modification	EHHADH AMACR RNF213 HADHA ACOX3	1.66e-04	214	50	5	GO:0030258
GeneOntologyBiologicalProcess	fatty acid catabolic process	EHHADH AMACR HADHA ACOX3	1.79e-04	116	50	4	GO:0009062
GeneOntologyBiologicalProcess	dehydroascorbic acid transport	SLC2A1 SLC2A4	2.05e-04	9	50	2	GO:0070837
GeneOntologyBiologicalProcess	fatty acid oxidation	EHHADH AMACR HADHA ACOX3	2.17e-04	122	50	4	GO:0019395
GeneOntologyBiologicalProcess	post-embryonic animal morphogenesis	ATRX GNAS	2.56e-04	10	50	2	GO:0009886
GeneOntologyBiologicalProcess	lipid oxidation	EHHADH AMACR HADHA ACOX3	2.69e-04	129	50	4	GO:0034440
GeneOntologyCellularComponent	trans-Golgi network membrane	BPNT2 TMEM165 GNAS COG8	1.49e-04	112	50	4	GO:0032588
GeneOntologyCellularComponent	microbody lumen	EHHADH AMACR ACOX3	3.09e-04	55	50	3	GO:0031907
GeneOntologyCellularComponent	peroxisomal matrix	EHHADH AMACR ACOX3	3.09e-04	55	50	3	GO:0005782
GeneOntologyCellularComponent	trans-Golgi network	BPNT2 TMEM165 GNAS SLC2A4 COG8	8.04e-04	306	50	5	GO:0005802
GeneOntologyCellularComponent	sarcolemma	GNAS POPDC2 SLC2A1 SLC2A4	1.10e-03	190	50	4	GO:0042383
Domain	3HC_DH_C	EHHADH HADHA	3.87e-05	4	48	2	IPR006108
Domain	3HCDH	EHHADH HADHA	3.87e-05	4	48	2	PF00725
Domain	3-OHacyl-CoA_DH_NAD-bd	EHHADH HADHA	3.87e-05	4	48	2	IPR006176
Domain	3-OHacyl-CoA_DH_CS	EHHADH HADHA	3.87e-05	4	48	2	IPR006180
Domain	3HCDH	EHHADH HADHA	3.87e-05	4	48	2	PS00067
Domain	3HCDH_N	EHHADH HADHA	3.87e-05	4	48	2	PF02737
Domain	Enoyl-CoA_hyd/isom_CS	EHHADH HADHA	1.79e-04	8	48	2	IPR018376
Domain	6PGD_dom_2	EHHADH HADHA	2.87e-04	10	48	2	IPR013328
Domain	ENOYL_COA_HYDRATASE	EHHADH HADHA	2.87e-04	10	48	2	PS00166
Domain	-	EHHADH HADHA	2.87e-04	10	48	2	1.10.1040.10
Domain	MFS_dom	SLCO2B1 SLC2A1 SLC16A12 SLC2A4	3.86e-04	134	48	4	IPR020846
Domain	Sugar/inositol_transpt	SLC2A1 SLC2A4	5.77e-04	14	48	2	IPR003663
Domain	Crotonase_core_superfam	EHHADH HADHA	8.58e-04	17	48	2	IPR001753
Domain	ECH_1	EHHADH HADHA	8.58e-04	17	48	2	PF00378
Domain	SUGAR_TRANSPORT_2	SLC2A1 SLC2A4	8.58e-04	17	48	2	PS00217
Domain	6-PGluconate_DH_C-like	EHHADH HADHA	1.08e-03	19	48	2	IPR008927
Domain	-	EHHADH HADHA	1.32e-03	21	48	2	3.90.226.10
Domain	ClpP/crotonase-like_dom	EHHADH HADHA	1.32e-03	21	48	2	IPR029045
Domain	zf-DHHC	ZDHHC18 ZDHHC24	1.58e-03	23	48	2	PF01529
Domain	SUGAR_TRANSPORT_1	SLC2A1 SLC2A4	1.72e-03	24	48	2	PS00216
Domain	DHHC	ZDHHC18 ZDHHC24	1.87e-03	25	48	2	PS50216
Domain	Znf_DHHC_palmitoyltrfase	ZDHHC18 ZDHHC24	1.87e-03	25	48	2	IPR001594
Domain	MFS	SLC2A1 SLC16A12 SLC2A4	2.69e-03	108	48	3	PS50850
Domain	Sugar_transporter_CS	SLC2A1 SLC2A4	3.05e-03	32	48	2	IPR005829
Domain	-	DAGLB KANSL3 ESD	3.54e-03	119	48	3	3.40.50.1820
Domain	AB_hydrolase	DAGLB KANSL3 ESD	3.54e-03	119	48	3	IPR029058
Domain	Sugar_tr	SLC2A1 SLC2A4	3.85e-03	36	48	2	PF00083
Domain	MFS_sugar_transport-like	SLC2A1 SLC2A4	3.85e-03	36	48	2	IPR005828
Pathway	REACTOME_PEROXISOMAL_LIPID_METABOLISM	EHHADH AMACR ACOX3	4.03e-05	28	34	3	MM15010
Pathway	REACTOME_PEROXISOMAL_LIPID_METABOLISM	EHHADH AMACR ACOX3	4.49e-05	29	34	3	M2286
Pathway	KEGG_TRYPTOPHAN_METABOLISM	MAOB EHHADH HADHA	1.19e-04	40	34	3	M980
Pathway	KEGG_FATTY_ACID_METABOLISM	EHHADH HADHA ACOX3	1.38e-04	42	34	3	M699
Pathway	WP_GLUCOSE_METABOLISM_IN_TRIPLENEGATIVE_BREAST_CANCER_CELLS	PDP1 SLC2A1	1.57e-04	8	34	2	M45525
Pathway	REACTOME_BETA_OXIDATION_OF_PRISTANOYL_COA	AMACR ACOX3	2.01e-04	9	34	2	M27294
Pathway	REACTOME_BETA_OXIDATION_OF_PRISTANOYL_COA	AMACR ACOX3	2.01e-04	9	34	2	MM14999
Pathway	KEGG_LIMONENE_AND_PINENE_DEGRADATION	EHHADH HADHA	2.51e-04	10	34	2	M17395
Pathway	WP_VALPROIC_ACID_PATHWAY	EHHADH HADHA	3.67e-04	12	34	2	M39371
Pathway	REACTOME_PEROXISOMAL_PROTEIN_IMPORT	EHHADH AMACR ACOX3	4.61e-04	63	34	3	M27915
Pathway	REACTOME_PEROXISOMAL_PROTEIN_IMPORT	EHHADH AMACR ACOX3	5.06e-04	65	34	3	MM15628
Pathway	WP_MITOCHONDRIAL_LONG_CHAIN_FATTY_ACID_BETAOXIDATION	EHHADH HADHA	6.63e-04	16	34	2	MM15841
Pathway	REACTOME_FATTY_ACID_METABOLISM	EHHADH AMACR HADHA ACOX3	7.14e-04	170	34	4	MM15573
Pathway	WP_MITOCHONDRIAL_LONG_CHAIN_FATTY_ACID_BETAOXIDATION	EHHADH HADHA	7.51e-04	17	34	2	M39365
Pathway	WP_CORI_CYCLE	SLC2A1 SLC2A4	7.51e-04	17	34	2	M39604
Pathway	REACTOME_FATTY_ACID_METABOLISM	EHHADH AMACR HADHA ACOX3	8.13e-04	176	34	4	M27854
Pathway	KEGG_PEROXISOME	EHHADH AMACR ACOX3	8.62e-04	78	34	3	M6391
Pathway	WP_MITOCHONDRIAL_FATTY_ACID_OXIDATION_DISORDERS	EHHADH HADHA	9.41e-04	19	34	2	M48049
Pathway	REACTOME_CELLULAR_HEXOSE_TRANSPORT	SLC2A1 SLC2A4	9.41e-04	19	34	2	MM14718
Pathway	REACTOME_CELLULAR_HEXOSE_TRANSPORT	SLC2A1 SLC2A4	1.15e-03	21	34	2	M27058
Pathway	KEGG_BIOSYNTHESIS_OF_UNSATURATED_FATTY_ACIDS	HADHA ACOX3	1.27e-03	22	34	2	M11673
Pathway	KEGG_BETA_ALANINE_METABOLISM	EHHADH HADHA	1.27e-03	22	34	2	M2668
Pathway	WP_OREXIN_RECEPTOR_PATHWAY	PDP1 GNAS SLC2A1 SLC2A4	1.31e-03	200	34	4	M48048
Pathway	WP_NAD_METABOLISM_IN_ONCOGENEINDUCED_SENESCENCE_AND_MITOCHONDRIAL_DYSFUNCTIONASSOCIATED_SENESCENCE	SLC2A1 SLC2A4	1.38e-03	23	34	2	M40059
Pathway	REACTOME_BIOLOGICAL_OXIDATIONS	BPNT2 MAOB ESD OPLAH	1.82e-03	219	34	4	MM14838
Pathway	REACTOME_BIOLOGICAL_OXIDATIONS	BPNT2 MAOB ESD OPLAH	1.85e-03	220	34	4	M10320
Pathway	REACTOME_PROTEIN_LOCALIZATION	EHHADH AMACR ACOX3	1.92e-03	103	34	3	MM15653
Pathway	REACTOME_PHASE_II_CONJUGATION_OF_COMPOUNDS	BPNT2 ESD OPLAH	2.14e-03	107	34	3	MM14595
Pathway	WP_EICOSANOID_METABOLISM_VIA_LIPOOXYGENASES_LOX	EHHADH ACOX3	2.20e-03	29	34	2	M39858
Pathway	REACTOME_PHASE_II_CONJUGATION_OF_COMPOUNDS	BPNT2 ESD OPLAH	2.26e-03	109	34	3	M18788
Pubmed	Mitochondrial protein interactome elucidated by chemical cross-linking mass spectrometry.	MAOB CLPB EHHADH PDP1 COQ6 HADHA NDUFV1	6.81e-07	343	51	7	28130547
Pubmed	Identification of PSD-95 palmitoylating enzymes.	ZDHHC18 ZDHHC24 GNAS	1.99e-06	17	51	3	15603741
Pubmed	In silico analysis of non-synonymous missense SNPs (nsSNPs) in CPE, GNAS genes and experimental validation in type II diabetes mellitus through Next Generation Sequencing.	CPE GNAS	2.11e-06	2	51	2	34029697
Pubmed	Insulin-sensitive regulation of glucose transport and GLUT4 translocation in skeletal muscle of GLUT1 transgenic mice.	SLC2A1 SLC2A4	2.11e-06	2	51	2	9854024
Pubmed	Regulation of GLUT transporters by flavonoids in androgen-sensitive and -insensitive prostate cancer cells.	SLC2A1 SLC2A4	2.11e-06	2	51	2	24932809
Pubmed	Targeting glucose consumption and autophagy in myeloma with the novel nucleoside analogue 8-aminoadenosine.	SLC2A1 SLC2A4	2.11e-06	2	51	2	19648108
Pubmed	The Glut1 and Glut4 glucose transporters are differentially expressed during perinatal and postnatal erythropoiesis.	SLC2A1 SLC2A4	2.11e-06	2	51	2	18796630
Pubmed	Indinavir uncovers different contributions of GLUT4 and GLUT1 towards glucose uptake in muscle and fat cells and tissues.	SLC2A1 SLC2A4	2.11e-06	2	51	2	12712244
Pubmed	Diabetes and obesity during pregnancy alter insulin signalling and glucose transporter expression in maternal skeletal muscle and subcutaneous adipose tissue.	SLC2A1 SLC2A4	2.11e-06	2	51	2	19955252
Pubmed	Role of AMACR (α-methylacyl-CoA racemase) and MFE-1 (peroxisomal multifunctional enzyme-1) in bile acid synthesis in mice.	EHHADH AMACR	2.11e-06	2	51	2	24735479
Pubmed	Differential effects of GLUT1 or GLUT4 overexpression on hexosamine biosynthesis by muscles of transgenic mice.	SLC2A1 SLC2A4	2.11e-06	2	51	2	8798515
Pubmed	3T3-L1 adipocyte glucose transporter (HepG2 class): sequence and regulation of protein and mRNA expression by insulin, differentiation, and glucose starvation.	SLC2A1 SLC2A4	2.11e-06	2	51	2	2190533
Pubmed	Distinct Akt phosphorylation states are required for insulin regulated Glut4 and Glut1-mediated glucose uptake.	SLC2A1 SLC2A4	2.11e-06	2	51	2	28589878
Pubmed	Somatic cell-like features of cloned mouse embryos prepared with cultured myoblast nuclei.	SLC2A1 SLC2A4	2.11e-06	2	51	2	12606377
Pubmed	A potential role for glucose transporters in the evolution of human brain size.	SLC2A1 SLC2A4	2.11e-06	2	51	2	21986508
Pubmed	Differential effects of GLUT-1 or GLUT-4 overexpression on insulin responsiveness in transgenic mice.	SLC2A1 SLC2A4	2.11e-06	2	51	2	7977725
Pubmed	Sequence, tissue distribution, and differential expression of mRNA for a putative insulin-responsive glucose transporter in mouse 3T3-L1 adipocytes.	SLC2A1 SLC2A4	2.11e-06	2	51	2	2654938
Pubmed	Insulin receptor and glucose transporters mRNA expression throughout the menstrual cycle in human endometrium: a physiological and cyclical condition of tissue insulin resistance.	SLC2A1 SLC2A4	6.32e-06	3	51	2	22971162
Pubmed	GLUT4, GLUT1, and GLUT8 are the dominant GLUT transcripts expressed in the murine left ventricle.	SLC2A1 SLC2A4	6.32e-06	3	51	2	22681646
Pubmed	Impact of pre-gestational and gestational diabetes mellitus on the expression of glucose transporters GLUT-1, GLUT-4 and GLUT-9 in human term placenta.	SLC2A1 SLC2A4	6.32e-06	3	51	2	27981520
Pubmed	Sustained hypoglycemia affects glucose transporter expression of human blood leukocytes.	SLC2A1 SLC2A4	6.32e-06	3	51	2	12064911
Pubmed	Triiodothyronine acutely stimulates glucose transport into L6 muscle cells without increasing surface GLUT4, GLUT1, or GLUT3.	SLC2A1 SLC2A4	6.32e-06	3	51	2	22663547
Pubmed	Expression of glucose transporters in epithelial ovarian carcinoma: correlation with clinical characteristics and tumor angiogenesis.	SLC2A1 SLC2A4	6.32e-06	3	51	2	17611657
Pubmed	Suppression of PPAR-gamma attenuates insulin-stimulated glucose uptake by affecting both GLUT1 and GLUT4 in 3T3-L1 adipocytes.	SLC2A1 SLC2A4	6.32e-06	3	51	2	17389706
Pubmed	Analysis of correlations between the placental expression of glucose transporters GLUT-1, GLUT-4 and GLUT-9 and selected maternal and fetal parameters in pregnancies complicated by diabetes mellitus.	SLC2A1 SLC2A4	6.32e-06	3	51	2	28969476
Pubmed	The insulin-sensitive glucose transporter, GLUT4, interacts physically with Daxx. Two proteins with capacity to bind Ubc9 and conjugated to SUMO1.	SLC2A1 SLC2A4	1.26e-05	4	51	2	11842083
Pubmed	Structural analysis of the GLUT1 facilitative glucose transporter (review).	SLC2A1 SLC2A4	1.26e-05	4	51	2	11681785
Pubmed	Kinetic analysis of the liver-type (GLUT2) and brain-type (GLUT3) glucose transporters in Xenopus oocytes: substrate specificities and effects of transport inhibitors.	SLC2A1 SLC2A4	1.26e-05	4	51	2	8457197
Pubmed	Placental glucose transfer and fetal growth.	SLC2A1 SLC2A4	1.26e-05	4	51	2	12583599
Pubmed	In vitro analysis of the glucose-transport system in GLUT4-null skeletal muscle.	SLC2A1 SLC2A4	1.26e-05	4	51	2	10455018
Pubmed	Cloning and characterization of the major insulin-responsive glucose transporter expressed in human skeletal muscle and other insulin-responsive tissues.	SLC2A1 SLC2A4	1.26e-05	4	51	2	2656669
Pubmed	The sentrin-conjugating enzyme mUbc9 interacts with GLUT4 and GLUT1 glucose transporters and regulates transporter levels in skeletal muscle cells.	SLC2A1 SLC2A4	1.26e-05	4	51	2	10655495
Pubmed	Age-associated alterations in cardiac and skeletal muscle glucose transporters, insulin and IGF-1 receptors, and PI3-kinase protein contents in the C57BL/6 mouse.	SLC2A1 SLC2A4	1.26e-05	4	51	2	10100151
Pubmed	α1A-Adrenergic receptor prevents cardiac ischemic damage through PKCδ/GLUT1/4-mediated glucose uptake.	SLC2A1 SLC2A4	1.26e-05	4	51	2	26832303
Pubmed	Prenatal Exposure to Sodium Arsenite Alters Placental Glucose 1, 3, and 4 Transporters in Balb/c Mice.	SLC2A1 SLC2A4	1.26e-05	4	51	2	26339590
Pubmed	Functional cloning of TUG as a regulator of GLUT4 glucose transporter trafficking.	SLC2A1 SLC2A4	1.26e-05	4	51	2	14562105
Pubmed	Extra-nuclear telomerase reverse transcriptase (TERT) regulates glucose transport in skeletal muscle cells.	SLC2A1 SLC2A4	1.26e-05	4	51	2	24970747
Pubmed	Immunohistochemical localization and quantification of glucose transporters in the mouse brain.	SLC2A1 SLC2A4	1.26e-05	4	51	2	11955709
Pubmed	Blood-Brain Barrier: From Physiology to Disease and Back.	SLCO2B1 SLC2A1 SLC16A12 SLC2A4	1.76e-05	105	51	4	30280653
Pubmed	A mitochondrial protein compendium elucidates complex I disease biology.	MAOB CLPB EHHADH AMACR PDP1 COQ6 HADHA NDUFV1 ACOX3	1.92e-05	1047	51	9	18614015
Pubmed	Leptin at gender-specific concentrations does not affect glucose transport, expression of glucose transporters and leptin receptors in human lymphocytes.	SLC2A1 SLC2A4	2.10e-05	5	51	2	25306890
Pubmed	Developmental expression and cellular localization of glucose transporter molecules during mouse preimplantation development.	SLC2A1 SLC2A4	2.10e-05	5	51	2	1638987
Pubmed	The glucose transporter family: structure, function and tissue-specific expression.	SLC2A1 SLC2A4	2.10e-05	5	51	2	8240230
Pubmed	Downregulation of metabolic gene expression in failing human heart before and after mechanical unloading.	SLC2A1 SLC2A4	2.10e-05	5	51	2	12145475
Pubmed	Prenatal expression of the GLUT4 glucose transporter in the mouse.	SLC2A1 SLC2A4	2.10e-05	5	51	2	10965149
Pubmed	Differential screening of a PCR-generated mouse embryo cDNA library: glucose transporters are differentially expressed in early postimplantation mouse embryos.	SLC2A1 SLC2A4	2.10e-05	5	51	2	1289053
Pubmed	Gene expression profiling in the human hypothalamus-pituitary-adrenal axis and full-length cDNA cloning.	PDP1 TMEM165 ESD NDUFV1	2.88e-05	119	51	4	10931946
Pubmed	Transcriptional repression of the C/EBP-alpha and GLUT4 genes in 3T3-L1 adipocytes by tumor necrosis factor-alpha. Regulations is coordinate and independent of protein synthesis.	SLC2A1 SLC2A4	3.15e-05	6	51	2	1618860
Pubmed	Whole-exome sequencing identifies mutations of TBC1D1 encoding a Rab-GTPase-activating protein in patients with congenital anomalies of the kidneys and urinary tract (CAKUT).	SLC2A1 SLC2A4	3.15e-05	6	51	2	26572137
Pubmed	Synip: a novel insulin-regulated syntaxin 4-binding protein mediating GLUT4 translocation in adipocytes.	SLC2A1 SLC2A4	3.15e-05	6	51	2	10394363
Pubmed	Glucose uptake mediated by glucose transporter 1 is essential for early tooth morphogenesis and size determination of murine molars.	SLC2A1 SLC2A4	3.15e-05	6	51	2	22226978
Pubmed	A proteome-wide perspective on peroxisome targeting signal 1(PTS1)-Pex5p affinities.	EHHADH AMACR ACOX3	3.77e-05	44	51	3	20178365
Pubmed	Variability in Streptavidin-Sepharose Matrix Quality Can Significantly Affect Proximity-Dependent Biotinylation (BioID) Data.	TMEM165 COQ6 HADHA GNAS SLC2A1 NDUFV1	4.30e-05	438	51	6	32628020
Pubmed	The tuberous sclerosis complex regulates trafficking of glucose transporters and glucose uptake.	SLC2A1 SLC2A4	4.41e-05	7	51	2	18511518
Pubmed	Selective breeding, quantitative trait locus analysis, and gene arrays identify candidate genes for complex drug-related behaviors.	EFNB3 RNF112	4.41e-05	7	51	2	12805289
Pubmed	Genetic variants in nuclear-encoded mitochondrial genes influence AIDS progression.	CLPB EHHADH AMACR PDP1 COQ6 HADHA NDUFV1 ACOX3	5.66e-05	926	51	8	20877624
Pubmed	WDR76 is a RAS binding protein that functions as a tumor suppressor via RAS degradation.	ANAPC1 TTC21A UBE3B	6.24e-05	52	51	3	30655611
Pubmed	Expression of hexokinases and glucose transporters in treated and untreated oesophageal adenocarcinoma.	SLC2A1 SLC2A4	7.54e-05	9	51	2	19554504
Pubmed	Transcriptional regulation of muscle-specific genes during myoblast differentiation.	SLC2A1 SLC2A4	7.54e-05	9	51	2	9600108
Pubmed	Neutral amino acid transporter ASCT1 is preferentially expressed in L-Ser-synthetic/storing glial cells in the mouse brain with transient expression in developing capillaries.	SLC2A1 SLC2A4	9.42e-05	10	51	2	12533615
Pubmed	Essential regulation of CNS angiogenesis by the orphan G protein-coupled receptor GPR124.	SLC2A1 NRP1	9.42e-05	10	51	2	21071672
Pubmed	Genetics of obesity: advances from rodent studies.	CPE SLC2A1	9.42e-05	10	51	2	8973143
Pubmed	Comparative interactome analysis of α-arrestin families in human and Drosophila.	HADHA GNAS PBXIP1 SLC2A1 NRP1	9.57e-05	313	51	5	38270169
Pubmed	Subcellular localization of transporters along the rat blood-brain barrier and blood-cerebral-spinal fluid barrier by in vivo biotinylation.	SLCO2B1 SLC2A1	1.15e-04	11	51	2	18619525
Pubmed	Neural Deletion of Glucose Transporter Isoform 3 Creates Distinct Postnatal and Adult Neurobehavioral Phenotypes.	SLC2A1 SLC2A4	1.15e-04	11	51	2	30232223
Pubmed	Chromosome localizations of genes for five cAMP-specific phosphodiesterases in man and mouse.	CPE SLC2A1	1.63e-04	13	51	2	8009369
Pubmed	Foxp1 suppresses cortical angiogenesis and attenuates HIF-1alpha signaling to promote neural progenitor cell maintenance.	SLC2A1 SLC2A4	1.90e-04	14	51	2	38600346
Pubmed	Gene expression analysis of the embryonic subplate.	CRIM1 HADHA SLC2A1 NRP1	1.99e-04	196	51	4	21862448
Pubmed	Irisin Mediates Effects on Bone and Fat via αV Integrin Receptors.	TMEM165 TTC21A RNF213 HADHA GNAS PBXIP1 SLC2A1 NDUFV1 NRP1	2.33e-04	1451	51	9	30550785
Pubmed	Pathway-based evaluation of 380 candidate genes and lung cancer susceptibility suggests the importance of the cell cycle pathway.	EFNB3 AMACR HADHA SLC2A1 SLC2A4	2.39e-04	381	51	5	18676680
Pubmed	Polymorphisms in innate immunity genes and lung cancer risk in Xuanwei, China.	EFNB3 AMACR HADHA SLC2A1 SLC2A4	2.42e-04	382	51	5	19170196
Pubmed	Rewiring of the Human Mitochondrial Interactome during Neuronal Reprogramming Reveals Regulators of the Respirasome and Neurogenesis.	BPNT2 BPIFB3 EHHADH PDP1 TMEM165 HADHA NDUFV1	2.46e-04	859	51	7	31536960
Pubmed	Pancreatic islet and progenitor cell surface markers with cell sorting potential.	EFNB3 SLC2A1 NRP1	2.79e-04	86	51	3	21947380
Pubmed	Mutations in linker-2 of KLF1 impair expression of membrane transporters and cytoskeletal proteins causing hemolysis.	SLC2A1 SLC2A4	2.83e-04	17	51	2	39147774
Pubmed	Glucose transporter gene expression in early mouse embryos.	SLC2A1 SLC2A4	3.18e-04	18	51	2	1765007
Pubmed	p115 Interacts with the GLUT4 vesicle protein, IRAP, and plays a critical role in insulin-stimulated GLUT4 translocation.	SLC2A1 SLC2A4	3.18e-04	18	51	2	15800058
Pubmed	Genetic susceptibility to distinct bladder cancer subphenotypes.	EFNB3 AMACR HADHA SLC2A1 SLC2A4	3.77e-04	421	51	5	19692168
Pubmed	Biochemistry of mammalian peroxisomes revisited.	AMACR ACOX3	3.94e-04	20	51	2	16756494
Pubmed	NMRK2 Gene Is Upregulated in Dilated Cardiomyopathy and Required for Cardiac Function and NAD Levels during Aging.	SLC2A1 SLC2A4	4.35e-04	21	51	2	33805532
Pubmed	Genetic variability of the fatty acid synthase pathway is not associated with prostate cancer risk in the European Prospective Investigation on Cancer (EPIC).	SLC2A1 SLC2A4	4.78e-04	22	51	2	20965718
Pubmed	Zic2-dependent axon midline avoidance controls the formation of major ipsilateral tracts in the CNS.	EFNB3 NRP1	5.23e-04	23	51	2	24360543
Pubmed	Interrogating the protein interactomes of RAS isoforms identifies PIP5K1A as a KRAS-specific vulnerability.	ZDHHC18 EFNB3 TMEM165 EPB41L5 GNAS	6.04e-04	467	51	5	30194290
Pubmed	Atrx deficiency induces telomere dysfunction, endocrine defects, and reduced life span.	ATRX NRP1	6.19e-04	25	51	2	23563309
Pubmed	ACAA2 is a ligand-dependent coactivator for thyroid hormone receptor β1.	ATRX EHHADH HADHA	6.21e-04	113	51	3	34474245
Pubmed	Semaphorin heterodimerization in cis regulates membrane targeting and neocortical wiring.	EFNB3 NRP1	6.70e-04	26	51	2	39152101
Pubmed	Ca2+ homeostasis maintained by TMCO1 underlies corpus callosum development via ERK signaling.	EFNB3 NRP1	6.70e-04	26	51	2	35927240
Pubmed	A neomorphic cancer cell-specific role of MAGE-A4 in trans-lesion synthesis.	HADHA GNAS SLC2A1	7.04e-04	118	51	3	27377895
Pubmed	Hypoxic regulation of hand1 controls the fetal-neonatal switch in cardiac metabolism.	SLC2A1 SLC2A4	7.23e-04	27	51	2	24086110
Pubmed	The phosphorylation status of T522 modulates tissue-specific functions of SIRT1 in energy metabolism in mice.	EHHADH SLC2A4	8.35e-04	29	51	2	28364022
Pubmed	Maternal diabetes alters transcriptional programs in the developing embryo.	ATRX SLC2A1	1.02e-03	32	51	2	19538749
Pubmed	High-resolution photocatalytic mapping of SARS-CoV-2 spike interactions on the cell surface.	EFNB3 TMEM165 SLC2A1 NRP1	1.07e-03	307	51	4	37499664
Pubmed	Quantitative high-confidence human mitochondrial proteome and its dynamics in cellular context.	MAOB CLPB AMACR PDP1 COQ6 HADHA NDUFV1	1.29e-03	1136	51	7	34800366
Pubmed	Characterization of potential S-nitrosylation sites in the myocardium.	COQ6 HADHA	1.29e-03	36	51	2	21278135
Pubmed	Tau interactome maps synaptic and mitochondrial processes associated with neurodegeneration.	MAOB HADHA GNAS SLC2A1 OPLAH	1.34e-03	558	51	5	35063084
Pubmed	Comprehensive interactome profiling of the human Hsp70 network highlights functional differentiation of J domains.	ATRX CLPB EPB41L5 HADHA GNAS PBXIP1 SLC2A1 NDUFV1	1.36e-03	1487	51	8	33957083
Pubmed	The RNA-mediated estrogen receptor α interactome of hormone-dependent human breast cancer cell nuclei.	BBX ATRX CLPB ANAPC1 EPB41L5 PBXIP1 SLC2A1 NDUFV1	1.41e-03	1497	51	8	31527615
Pubmed	Chemical Crosslinking Mass Spectrometry Analysis of Protein Conformations and Supercomplexes in Heart Tissue.	MAOB COQ6 HADHA NDUFV1	1.42e-03	331	51	4	29199018
Pubmed	Hearts of hypoxia-inducible factor prolyl 4-hydroxylase-2 hypomorphic mice show protection against acute ischemia-reperfusion injury.	SLC2A1 SLC2A4	1.43e-03	38	51	2	20185832
Interaction	ARMCX3 interactions	FAM25G EHHADH FAM25A GNAS FAM25C NDUFV1	9.24e-07	133	50	6	int:ARMCX3
Interaction	TOMM20L interactions	FAM25G FAM25A FAM25C	1.70e-06	10	50	3	int:TOMM20L
Interaction	IGLL1 interactions	FAM25G FAM25A FAM25C	3.11e-06	12	50	3	int:IGLL1
Interaction	KLHL35 interactions	FAM25G FAM25A FAM25C	6.40e-06	15	50	3	int:KLHL35
Interaction	COQ8B interactions	CLPB AMACR TMEM165 COQ6 SLC2A1	7.70e-06	110	50	5	int:COQ8B
Interaction	ZFAND3 interactions	FAM25G FAM25A FAM25C	9.54e-06	17	50	3	int:ZFAND3
Interaction	GPD1 interactions	FAM25G FAM25A FAM25C	2.46e-05	23	50	3	int:GPD1
Interaction	PPIC interactions	FAM25G FAM25A FAM25C	3.59e-05	26	50	3	int:PPIC
Interaction	REL interactions	ZDHHC24 ARL16 EHHADH TMEM165 TTC21A RNF213 HADHA	4.55e-05	388	50	7	int:REL
Interaction	COX16 interactions	FAM25G FAM25A FAM25C	6.15e-05	31	50	3	int:COX16
Interaction	CPT2 interactions	AMACR HADHA GNAS NRP1	8.32e-05	93	50	4	int:CPT2
Interaction	MIEF2 interactions	FAM25G FAM25A FAM25C	8.89e-05	35	50	3	int:MIEF2
Interaction	ARMC10 interactions	FAM25G FAM25A FAM25C	1.05e-04	37	50	3	int:ARMC10
Interaction	PTGES2 interactions	HADHA PBXIP1 OPLAH NRP1	1.10e-04	100	50	4	int:PTGES2
Cytoband	10q11.22	FAM25G FAM25C	9.65e-04	41	51	2	10q11.22
Cytoband	Ensembl 112 genes in cytogenetic band chr11q13	ZDHHC24 CLPB SLCO2B1 NDUFV1	1.63e-03	454	51	4	chr11q13
GeneFamily	Zinc fingers DHHC-type\|Ankyrin repeat domain containing	ZDHHC18 ZDHHC24	6.71e-04	24	29	2	76
GeneFamily	Solute carriers	SLCO2B1 SLC2A1 SLC16A12 SLC2A4	3.46e-03	395	29	4	752
ToppCell	3'-GW_trimst-2-SmallIntestine-Mesenchymal-fibroblastic-mLTo\|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract	SLCO2B1 CPE POPDC2 NRP1	3.14e-05	157	51	4	c779a53b2c67d566f5d417e753cd17196a6bfd1c
ToppCell	droplet-Kidney-nan-18m-Epithelial-Epcam____proximal_tube_epithelial_cell\|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation	EHHADH AMACR CPE ACOX3	3.90e-05	166	51	4	8ab18c9d911eb3a9970bba7a769294b0927538f7
ToppCell	PND10-Mesenchymal-Mesenchymal_structural-Fibroblastic-Mesothelial-Mesothelial_mature\|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	DAGLB RNF112 CLDN15 CPE	3.99e-05	167	51	4	d50311b1f66f143bae4c4cf50e2e9b13c85d6920
ToppCell	PND10-Mesenchymal-Mesenchymal_structural-Fibroblastic-Mesothelial\|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	DAGLB RNF112 CLDN15 CPE	3.99e-05	167	51	4	7abc785e688a384672d7fb5a62d32538fe7e5a51
ToppCell	droplet-Kidney-nan-3m-Epithelial-epithelial_cell_of_proximal_tubule\|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation	EHHADH AMACR CPE ACOX3	4.38e-05	171	51	4	05fcc72df50a380a913821b5781d9621df37d328
ToppCell	droplet-Kidney-nan-3m-Epithelial-Epcam____proximal_tube_epithelial_cell\|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation	EHHADH AMACR CPE ACOX3	4.38e-05	171	51	4	48fc4eca18b102b5ec5050f758281292ee8e10c6
ToppCell	PND03-Mesenchymal-Mesenchymal_structural-Fibroblastic-Mesothelial\|PND03 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	CRIM1 RNF112 CLDN15 CPE	4.58e-05	173	51	4	30d67738633493d47f06ae452424382f069b6c0a
ToppCell	PND03-Mesenchymal-Mesenchymal_structural-Fibroblastic-Mesothelial-Mesothelial_mature\|PND03 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	CRIM1 RNF112 CLDN15 CPE	4.69e-05	174	51	4	a9c6edf5c3fc119c24425f921c5566a8356c30fe
ToppCell	droplet-Pancreas-PANCREAS-30m-Epithelial-pancreatic_A_cell\|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	ATRX CPE GNAS PBXIP1	5.01e-05	177	51	4	426a9845df7fd13b02e744532c336c60bc4d4a22
ToppCell	P03-Endothelial-lymphatic_endothelial_cell-endothelial_cell_of_lymphatic_vessel\|P03 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase	DAGLB SLCO2B1 CPE GNAS	5.70e-05	183	51	4	89727b4f65949ed2dce9d2e0228c79fe4280230c
ToppCell	P03-Endothelial-lymphatic_endothelial_cell\|P03 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase	DAGLB SLCO2B1 CPE GNAS	5.70e-05	183	51	4	113e6d8d4bb271be984af06cd6c22b180425dcfc
ToppCell	E17.5-Mesenchymal-mesenchymal_fibroblast-mesothelial_cell_of_visceral_pleura\|E17.5 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase	CRIM1 RNF112 CLDN15 CPE	5.82e-05	184	51	4	607b55022de21ddb6a2d75e085df76df7abf6624
ToppCell	E12.5-Mesenchymal-mesenchymal_fibroblast-mesothelial_cell_of_visceral_pleura\|E12.5 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase	RNF112 RNF213 CLDN15 CPE	6.07e-05	186	51	4	1587667e5084ac43505d027af925ba711e228150
ToppCell	droplet-Lung-1m-Endothelial-arterial_endothelial\|1m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	CRIM1 RNF112 CLDN15 CPE	6.07e-05	186	51	4	ffbc78058be8f0dc2e0335cc4c3195a636d17721
ToppCell	droplet-Lung-1m-Endothelial-arterial_endothelial-pulmonary_artery_endothelial_cell\|1m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	CRIM1 RNF112 CLDN15 CPE	6.07e-05	186	51	4	ed924852cd7132c8f6703522037dc22bd2c83193
ToppCell	droplet-Mammary_Gland-nan-21m-Endothelial-endothelial_cell\|Mammary_Gland / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation	CRIM1 SLCO2B1 CLDN15 NRP1	6.33e-05	188	51	4	05de6677f9bb4b00fed47f4b72f4a2cd507cb0f2
ToppCell	droplet-Mammary_Gland-nan-21m-Endothelial-endothelial_cell\|Mammary_Gland / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation	CRIM1 SLCO2B1 CLDN15 NRP1	6.46e-05	189	51	4	8ced0381ea042ba47680a02b617a2368fa2c54c8
ToppCell	droplet-Mammary_Gland-nan-21m-Endothelial\|Mammary_Gland / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation	CRIM1 SLCO2B1 CLDN15 NRP1	6.46e-05	189	51	4	403a82bb416aed13b9d31411ad17bdc4ce2a95fb
ToppCell	facs-Pancreas-Endocrine-3m-Epithelial\|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	BBX MAOB CPE GNAS	6.73e-05	191	51	4	657297cd19d05a7e7bb74fc3a086fbd95f47aae4
ToppCell	facs-Pancreas-Endocrine\|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	MAOB CPE GNAS SLC16A12	7.01e-05	193	51	4	15c86e20b97b6983410b36d308cddff56d141c98
ToppCell	ASK452-Endothelial-Lymphatic\|Endothelial / Donor, Lineage and Cell class of Lung cells from Dropseq	SH3GL1 COQ6 CLDN15 NDUFV1	7.29e-05	195	51	4	20f492299a684ac1b7dd1bbc36a533cd6f9a1c93
ToppCell	Adult-Mesenchymal-matrix_fibroblast_1_cell-D122\|Adult / Lineage, Cell type, age group and donor	CRIM1 MAOB RNF112 SLC16A12	7.29e-05	195	51	4	aa0add081881d349099d12efca5cdee098038d4e
ToppCell	droplet-Trachea-nan-3m-Mesenchymal-chondrocyte\|Trachea / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation	CRIM1 CPE FAM25C SLC2A1	7.58e-05	197	51	4	8786125b669d5d0b15e12df0ade6b319f09f7333
ToppCell	TCGA-Skin-Metastatic-Melanoma\|TCGA-Skin / Sample_Type by Project: Shred V9	BBX ATRX SLCO2B1 NRP1	7.73e-05	198	51	4	af4fb9eb2295c7b90624b38ba25619aa15254efa
ToppCell	TCGA-Skin-Metastatic-Melanoma-Skin_Cutaneous_Melanoma\|TCGA-Skin / Sample_Type by Project: Shred V9	BBX ATRX SLCO2B1 NRP1	7.73e-05	198	51	4	62cbf4b29e8af4983fb47a17f96da62682a5137e
ToppCell	TCGA-Skin-Metastatic\|TCGA-Skin / Sample_Type by Project: Shred V9	BBX ATRX SLCO2B1 NRP1	7.73e-05	198	51	4	ad39cce004867f083f8da1954e0cf5a263815184
ToppCell	LPS_IL1RA-Endothelial-Endothelial-Gen_Cap\|LPS_IL1RA / Treatment groups by lineage, cell group, cell type	ATRX SLCO2B1 RNF213 NRP1	8.04e-05	200	51	4	dccec522ab0d7fff62ad6273b02aa9022dbbb8eb
ToppCell	Parenchymal-10x5prime-Stromal-Peri/Epineurial_-NAF_epineurial\|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations	CRIM1 MAOB NYAP1 SLC2A1	8.04e-05	200	51	4	36de49593cf6ff1c9229fcceb150c1d68658a360
ToppCell	LPS_IL1RA_TNF-Mesenchymal_myocytic-Pericyte-Pericyte_3\|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type	CRIM1 CPE POPDC2 SLC2A4	8.04e-05	200	51	4	c06426f877919bdd267ea2fd7e7973c6619832ae
Drug	trihydroxycholestanoic acid	EHHADH AMACR HADHA ACOX3	1.63e-07	23	49	4	CID000122312
Drug	AC1L1AH5	EHHADH ESD RNF112 COQ6 HADHA ACOX3 COG8	3.73e-07	215	49	7	CID000000986
Drug	BR931	EHHADH COQ6 HADHA ACOX3	3.73e-07	28	49	4	CID000068851
Drug	AC1NORN3	EHHADH HADHA ACOX3	2.03e-06	12	49	3	CID005118011
Drug	AC1NOS53	EHHADH HADHA ACOX3	2.03e-06	12	49	3	CID005118245
Drug	AC1NORMX	EHHADH HADHA ACOX3	2.64e-06	13	49	3	CID005118009
Drug	AC1NPX1L	EHHADH HADHA ACOX3	3.35e-06	14	49	3	CID005165851
Drug	Ethynylestradiol 3-methyl ether [72-33-3]; Down 200; 12.8uM; MCF7; HT_HG-U133A	BPNT2 PDP1 CLDN15 CPE PBXIP1 NRP1	4.11e-06	198	49	6	4792_DN
Drug	2-methylpalmitate	EHHADH HADHA ACOX3	4.19e-06	15	49	3	CID000117384
Drug	T2-decenoyl-CoA	EHHADH HADHA ACOX3	4.19e-06	15	49	3	CID000656483
Drug	Etidronic acid, disodium salt [7414-83-7]; Up 200; 16uM; MCF7; HT_HG-U133A	KANSL3 CHRNA6 EFNB3 AMACR SERGEF SLC2A1	4.35e-06	200	49	6	4387_UP
Drug	perfluorodecanoic acid	EHHADH COQ6 HADHA ACOX3	4.39e-06	51	49	4	CID000009555
Drug	varanic acid	EHHADH HADHA ACOX3	5.14e-06	16	49	3	CID003080578
Drug	lactate	CLPB EHHADH PDP1 SLC2A1 SLC16A12 NDUFV1 SLC2A4 OPLAH	5.79e-06	461	49	8	CID000000612
Drug	cetaben	EHHADH COQ6 ACOX3	6.24e-06	17	49	3	CID000047263
Drug	malonyl-coenzyme A	PDP1 RNF112 HADHA SLC2A4 ACOX3	7.52e-06	126	49	5	CID000000869
Drug	AC1NORN0	EHHADH HADHA ACOX3	8.86e-06	19	49	3	CID005118010
Drug	AC1L193Y	EHHADH PDP1 HADHA ACOX3	1.16e-05	65	49	4	CID000000380
Drug	hexaglycine	SLC2A1 SLC2A4	1.36e-05	3	49	2	CID000138069
Drug	Hexoses	SLC2A1 SLC2A4	1.36e-05	3	49	2	ctd:D006601
Drug	AC1NQZWV	EHHADH HADHA	1.36e-05	3	49	2	CID005282342
Drug	HMDB06870	EHHADH HADHA	1.36e-05	3	49	2	CID011953876
Drug	3-oxopalmitoyl-CoA	EHHADH HADHA ACOX3	1.40e-05	22	49	3	CID000169621
Drug	perfluorobutanesulfonic acid	EHHADH SLCO2B1 HADHA	1.61e-05	23	49	3	ctd:C539348
Drug	AC1Q68Z4	EHHADH HADHA ACOX3	2.35e-05	26	49	3	CID000000877
Drug	3-quinuclidinone	EHHADH HADHA	2.71e-05	4	49	2	CID000019507
Drug	n-propionyl-CoA	EHHADH PDP1 ESD HADHA ACOX3	2.85e-05	166	49	5	CID000001033
Drug	AC1L19XE	EHHADH COQ6 HADHA ACOX3	3.07e-05	83	49	4	CID000000744
Drug	beta-hydroxybutyrate	PDP1 HADHA SLC2A1 NDUFV1 SLC2A4	4.09e-05	179	49	5	CID000000441
Drug	octanoate	EHHADH PDP1 HADHA SLC16A12 ACOX3	4.31e-05	181	49	5	CID000000379
Drug	AC1NQZDQ	EHHADH HADHA	4.52e-05	5	49	2	CID005281997
Drug	3-hydroxy-4-trans-decenoyl-CoA	EHHADH HADHA	4.52e-05	5	49	2	CID006439025
Drug	clofibrate	EHHADH RNF112 COQ6 HADHA ACOX3 COG8	5.28e-05	311	49	6	CID000002796
Drug	rosiglitazone maleate; Up 200; 10uM; PC3; HG-U133A	EFNB3 CRIM1 TMEM165 SH3GL1 CPE	5.57e-05	191	49	5	430_UP
Drug	lauric acid	EHHADH ESD COQ6 HADHA ACOX3	5.85e-05	193	49	5	CID000003893
Drug	Pilocarpine nitrate [148-72-1]; Down 200; 14.8uM; PC3; HT_HG-U133A	WDR4 AMACR CLDN15 GNAS ACOX3	6.45e-05	197	49	5	6741_DN
Drug	N6-methyladenosine [1867-73-8]; Down 200; 14.2uM; MCF7; HT_HG-U133A	EHHADH PDP1 CLDN15 GNAS NRP1	6.45e-05	197	49	5	5332_DN
Drug	tetracosahexaenoic acid	EHHADH ACOX3	6.77e-05	6	49	2	CID006439582
Drug	myrcen-8-ol	EHHADH HADHA	6.77e-05	6	49	2	CID005319723
Drug	YC-17	SLC2A1 SLC2A4	6.77e-05	6	49	2	CID005282032
Drug	AC1NOS59	EHHADH HADHA	6.77e-05	6	49	2	CID005118247
Drug	AC1NOS56	EHHADH HADHA	6.77e-05	6	49	2	CID005118246
Drug	AC1L18GG	EHHADH HADHA	6.77e-05	6	49	2	CID000000090
Drug	dichloroacetamide	PDP1 COQ6	6.77e-05	6	49	2	CID000012694
Drug	estradiol enanthate	SH3GL1 SLC2A1	6.77e-05	6	49	2	CID000021070
Drug	LK-903	HADHA ACOX3	6.77e-05	6	49	2	CID006443773
Drug	acrylyl-coenzyme A	EHHADH HADHA ACOX3	6.91e-05	37	49	3	CID000439340
Drug	Benoxinate hydrochloride [5987-82-6]; Down 200; 11.6uM; MCF7; HT_HG-U133A	ZDHHC18 EFNB3 CRIM1 CLDN15 CPE	6.93e-05	200	49	5	1476_DN
Drug	AC1L9EU5	EHHADH HADHA	9.46e-05	7	49	2	CID000443525
Drug	[R,S]-Lactyl CoA	EHHADH HADHA	9.46e-05	7	49	2	CID000440609
Drug	AC1L99M6	EHHADH HADHA	9.46e-05	7	49	2	CID000440603
Drug	AC1L99MC	EHHADH HADHA	9.46e-05	7	49	2	CID000440605
Drug	AC1L99MI	EHHADH HADHA	9.46e-05	7	49	2	CID000440607
Drug	Methapyrilene	MAOB SLCO2B1 AMACR PDP1 SLC2A1 OPLAH	9.66e-05	347	49	6	ctd:D008701
Drug	decanoyl-CoA	EHHADH HADHA ACOX3	1.09e-04	43	49	3	CID000164800
Drug	flavin adenine dinucleotide sodium	MAOB EHHADH COQ6 HADHA NDUFV1 ACOX3	1.11e-04	356	49	6	CID000000703
Drug	FAD semiquinone	MAOB SLC16A12 NDUFV1 ACOX3	1.17e-04	117	49	4	CID000001072
Drug	Zidovudine	SLCO2B1 TTC21A RNF213 HADHA SLC2A1 NDUFV1 SLC2A4	1.18e-04	521	49	7	ctd:D015215
Drug	AC1N3SS3	EHHADH HADHA ACOX3	1.25e-04	45	49	3	CID000000592
Drug	AC1L99M3	EHHADH HADHA	1.26e-04	8	49	2	CID000440602
Drug	Aripiprazole	MAOB SLCO2B1 PDP1	1.42e-04	47	49	3	ctd:D000068180
Drug	trimethylthiophosphate	ESD COQ6	1.62e-04	9	49	2	CID000009038
Drug	3-oxo-octanoyl-coenzyme A	EHHADH HADHA	1.62e-04	9	49	2	CID000440608
Drug	AC1L99M9	EHHADH HADHA	1.62e-04	9	49	2	CID000440604
Drug	AC1L99MF	EHHADH HADHA	1.62e-04	9	49	2	CID000440606
Drug	Co-O	EHHADH HADHA	1.62e-04	9	49	2	CID009547993
Drug	NBDG	SLC2A1 SLC2A4	1.62e-04	9	49	2	CID000163790
Drug	bromopropylate	COQ6 CPE	2.02e-04	10	49	2	CID000028936
Drug	4-cis-decenoyl-CoA	HADHA ACOX3	2.02e-04	10	49	2	CID006443609
Drug	sodium cholate	EHHADH SLCO2B1 AMACR COQ6 HADHA ACOX3	2.33e-04	408	49	6	CID000000303
Drug	tetradecanedioate	EHHADH HADHA	2.46e-04	11	49	2	CID000013185
Drug	cyclic HPMPC	CPE GNAS	2.46e-04	11	49	2	CID000122873
Drug	9,10-diphenylanthracene	PDP1 CPE	2.46e-04	11	49	2	CID000015159
Drug	3-Hydroxybutanoyl-Coenzyme A	EHHADH HADHA ACOX3	2.53e-04	57	49	3	CID000000521
Drug	carnitine	EHHADH PDP1 HADHA SLC2A4 ACOX3	2.58e-04	265	49	5	CID000000085
Drug	pyruvic acid	CLPB PDP1 SLC2A1 SLC16A12 NDUFV1 SLC2A4	2.86e-04	424	49	6	CID000001060
Drug	formate	PDP1 ESD NDUFV1 ACOX3 COG8	2.86e-04	271	49	5	CID000000283
Drug	AC1LASJR	EHHADH ESD HADHA	2.94e-04	60	49	3	CID000474231
Drug	AC1L6D6Y	ESD CPE	2.95e-04	12	49	2	CID000265082
Drug	Acarbose	SLC2A1 SLC2A4	2.95e-04	12	49	2	ctd:D020909
Drug	3-hydroxyisobutyryl-CoA	EHHADH HADHA	2.95e-04	12	49	2	CID000000088
Drug	3-ketohexanoyl-CoA	EHHADH HADHA	2.95e-04	12	49	2	CID000440610
Drug	AC1L99WA	EHHADH HADHA	2.95e-04	12	49	2	CID000440753
Drug	IAPS-forskolin	SLC2A1 SLC2A4	2.95e-04	12	49	2	CID000163853
Drug	D 8731	SLC2A1 SLC2A4	2.95e-04	12	49	2	CID000132562
Drug	C24:0	EHHADH HADHA ACOX3	3.09e-04	61	49	3	CID000011197
Drug	3-chloropropionyl-CoA	EHHADH HADHA	3.49e-04	13	49	2	CID000125892
Drug	pristanic acid	AMACR HADHA ACOX3	3.56e-04	64	49	3	CID000123929
Drug	AC1L1A2K	EHHADH HADHA ACOX3	3.90e-04	66	49	3	CID000000808
Drug	Ethylnitrosourea	CHRNA6 ATRX PDP1 EPB41L5 GNAS	3.97e-04	291	49	5	ctd:D005038
Drug	ATB-BMPA	SLC2A1 SLC2A4	4.06e-04	14	49	2	CID000122117
Drug	isocarboxazid	MAOB ESD	4.06e-04	14	49	2	CID000003759
Disease	Endocrine System Diseases	CPE GNAS	8.78e-06	3	51	2	C0014130
Disease	event-related brain oscillation	KANSL3 GNAS	1.75e-05	4	51	2	EFO_0004358
Disease	Degenerative polyarthritis	ESD HADHA SLC2A1 NDUFV1	2.06e-05	93	51	4	C0029408
Disease	Osteoarthrosis Deformans	ESD HADHA SLC2A1 NDUFV1	2.06e-05	93	51	4	C0086743
Disease	pancreatic hormone measurement	FAM25G FAM25C	1.31e-04	10	51	2	EFO_0020621
Disease	Insulin Sensitivity	CPE GNAS SLC2A4	1.55e-04	60	51	3	C0920563
Disease	Insulin Resistance	CPE GNAS SLC2A4	1.55e-04	60	51	3	C0021655
Disease	obesity (is_implicated_in)	PDP1 GNAS SLC2A1	5.31e-04	91	51	3	DOID:9970 (is_implicated_in)
Disease	Anoxemia	ESD GNAS	1.49e-03	33	51	2	C0003129
Disease	Hypoxemia	ESD GNAS	1.49e-03	33	51	2	C0700292
Disease	Hypoxia	ESD GNAS	1.49e-03	33	51	2	C0242184
Disease	Anoxia	ESD GNAS	1.49e-03	33	51	2	C0003130

Protein segments in the cluster

Peptide	Gene	Start	Entry
FGHSMGGHGALICAL	ESD	146	P10768
MHCSGPLGGLLQLAA	BPIFB3	121	P59826
GGLSMLLLAGEHALG	BBX	206	Q8WY36
CGGHGYLAMNRLGVL	ACOX3	426	O15254
ADFAGGGLMCALGII	AMACR	151	Q9UHK6
SGGGLVGAAMACALG	COQ6	41	Q9Y2Z9
AKHGMCLLLGATGVG	ARL16	21	Q0P5N6
LGRTALMHACAGGGG	ANKRD34A	76	Q69YU3
LAAGLALGMVCLGHG	ANAPC1	1296	Q9H1A4
ALGMVCLGHGSNLIG	ANAPC1	1301	Q9H1A4
LAHHMALGLLFLGGG	ANAPC1	1556	Q9H1A4
GGGISGMAAAKLLHD	MAOB	11	P27338
MLGGLGKLAAEGLAH	FAM25G	1	B3EWG6
LHLIGLAGMAGCAIL	SLC2A1	336	P11166
TLHLLGLAGMCGCAI	SLC2A4	351	P14672
GMAFGGGLELALGCH	EHHADH	96	Q08426
MLGGLGKLAAEGLAH	FAM25A	1	B3EWG3
RGIGGHLDSLLGQCM	COG8	336	Q96MW5
GRGRELAQALGCMHG	LRRC29	16	Q8WV35
ICAGNAILKALGGHM	BPNT2	301	Q9NX62
RGMLLGVFDGHAGCA	PDP1	136	Q9P0J1
HGGLGLRMELLGCEV	NRP1	571	O14786
MLTSKGQGFLHGGLC	CHRNA6	1	Q15825
PGSGCILAHCMGLGK	ATRX	1586	P46100
GLAGCEMLLTGKEGH	EPB41L5	676	Q9HCM4
AGILGAGALIAGMCF	IGSF23	161	A1L1A6
LMHRGKLDCAGGALL	DAGLB	41	Q8NCG7
GHSLGGGAAALLATM	DAGLB	441	Q8NCG7
MAGRGGSALLALCGA	CPE	1	P16870
MYLVAGDRGLAGCGH	CRIM1	1	Q9NZV1
GALHILAGICGMVAI	CLDN15	121	P56746
VKHLAILGAGLMGAG	HADHA	361	P40939
GSGVGVLQCLEHMIG	KANSL3	316	Q9P2N6
AGLGMCALAAALVVH	CLPB	111	Q9H078
ALLLLGVAGAGGAMC	EFNB3	236	Q15768
LGLGGCGLIVKHGMT	FAM87A	141	P0C7U9
GAMGAAAGVLHHRGC	NYAP1	516	Q6ZVC0
MLGGLGKLAAEGLAH	FAM25C	1	B3EWG5
GLLVGCGAGHSLALC	SERGEF	386	Q9UGK8
HLSCQVGIMLGGLLA	SLC16A12	111	Q6ZSM3
HKLLEGCLVGGRAMG	NDUFV1	136	P49821
AGGQHACAIARALGM	OPLAH	491	O14841
MCTHRLLLLGAGESG	GNAS	681	Q5JWF2
TLGHCLAHLAGMGGS	RNF213	1801	Q63HN8
GLLGECMIRHGKELG	SH3GL1	91	Q99961
GAGGELGISLNMCLL	PBXIP1	186	Q96AQ6
HLAAVGGAVGAGLMG	RNF112	546	Q9ULX5
HLGPVGCGALCLLGM	SLCO2B1	436	O94956
HLANCLLLLGFMGGS	POPDC2	31	Q9HBU9
GHCLCTGLAVIGGRM	TMEM165	276	Q9HC07
DGMAGLTGIILCHIL	TTC21A	366	Q8NDW8
GALLCGAGLLFHGML	ZDHHC24	206	Q6UX98
GCHTLCLMGNLLHLG	UBE3B	306	Q7Z3V4
GCGRLELGHLSMLLD	WDR4	136	P57081
CGGRLMLAGHGGVFA	ZDHHC18	81	Q9NUE0